InvestorsHub Logo

Threepointer

09/28/20 7:46 PM

#236533 RE: 4toSchool #236529

Really, still blaming Andy? The fact is that the fda had no category or understanding of actipatch to clear it DESPITE THE FACT THAT THEY CLEARED ACTIBAND USING THE SAME TECHNOLOGY. This really isn’t that difficult a concept. They wasted a lot of money getting this last and most important clearance. All the bs is IN THE PAST. I think I’ll focus on the future now, as I’ve explained this way too often. I just split that bucket in two for the last time. Next.

toohot

09/28/20 9:03 PM

#236534 RE: 4toSchool #236529

You're kidding right? AW got off cheap compared to normal FDA approval costs. Albeit, a bit longer than expected but all the TRUE longs had the patience to wait it out. Gold mining here is coming to fruition.




$BIEL$